Pfizer says its experimental antiviral pill for Covid-19 cut rates of hospitalisation and death by nearly 90 per cent in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus.Currently…
Source: NZ Herald Business News